JPY3,087.00
0.68% today
Tokyo, Nov 26, 07:15 am CET
ISIN
JP3546800008
Symbol
4543
Index
Sector

Terumo Stock price

JPY3,096.00
+209.50 7.26% 1M
+396.50 14.69% 6M
+785.00 33.97% YTD
+721.00 30.36% 1Y
+592.50 23.67% 3Y
+1,164.50 60.29% 5Y
+2,423.00 360.03% 10Y
Tokyo, Closing price Tue, Nov 26 2024
-12.00 0.39%
ISIN
JP3546800008
Symbol
4543
Index
Sector

Key metrics

Market capitalization JPY4.61t
Enterprise Value JPY4.59t
P/E (TTM) P/E ratio 38.64
EV/FCF (TTM) EV/FCF 35.49
EV/Sales (TTM) EV/Sales 4.65
P/S ratio (TTM) P/S ratio 4.68
P/B ratio (TTM) P/B ratio 3.51
Dividend yield 0.84%
Last dividend (FY25) JPY26.00
Revenue growth (TTM) Revenue growth 14.63%
Revenue (TTM) Revenue JPY986.67b
EBIT (operating result TTM) EBIT JPY161.48b
Free Cash Flow (TTM) Free Cash Flow JPY129.40b
Cash position JPY194.92b
EPS (TTM) EPS JPY80.43
P/E forward 35.46
P/S forward 4.51
EV/Sales forward 4.49
Show more

Is Terumo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Terumo Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Terumo forecast:

12x Buy
75%
4x Hold
25%

Analyst Opinions

16 Analysts have issued a Terumo forecast:

Buy
75%
Hold
25%

Financial data from Terumo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
986,674 986,674
15% 15%
100%
- Direct Costs 458,732 458,732
9% 9%
46%
527,942 527,942
20% 20%
54%
- Selling and Administrative Expenses 284,657 284,657
58% 58%
29%
- Research and Development Expense - -
-
-
243,285 243,285
25% 25%
25%
- Depreciation and Amortization 81,805 81,805
13% 13%
8%
EBIT (Operating Income) EBIT 161,480 161,480
32% 32%
16%
Net Profit 119,486 119,486
21% 21%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about Terumo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Head office Japan
CEO Hikaru Samejima
Employees 30,591
Founded 1921
Website www.terumo.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today